Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01484054 · ClinicalTrials.gov registry record · NA

Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed Lens

A NA study of Refractive Ametropia, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
103
Enrollment target
6
Study locations

NCT01484054 is a NA study of Refractive Ametropia that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 103 participants, below the 214-participant average among 5 other Refractive Ametropia trials with a reported enrollment target (52% lower). The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01484054, a NA study of Refractive Ametropia, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
103 participants
Enrollment target
6
Study locations

Study Summary

To evaluate and compare the performance of a new contact lens to a marketed contact lens.

Conditions Studied

Refractive Ametropia

Interventions

  • DEVICE etafilcon A with print and PVP for dark eyes (EAPVPDE)
  • DEVICE etafilcon A control lens (EADE)

Study Locations (6)

Pennsylvania

  • - Kingston
  • - Moon Township

Connecticut

  • - Bloomfield

Florida

  • - Tallahassee

Kansas

  • - Overland Park

New York

  • - Jamestown

Trial Details

FieldValue
Enrollment Target 103 participants
Start Date 2011-11
Est. Completion 2012-02
Phase NA

Sponsor

Johnson & Johnson Vision Care

142 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01484054

The ClinicalTrials.gov registry entry for NCT01484054 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 214-participant average among 5 other Refractive Ametropia trials with a reported enrollment target (52% lower). The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Refractive Ametropia appearing as the primary indexed condition, and to 2 interventions - of which etafilcon A with print and PVP for dark eyes (EAPVPDE) is the first listed.

NCT01484054 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Pennsylvania, Connecticut, Florida.

Frequently Asked Questions

What is clinical trial NCT01484054 about?

NCT01484054 is a clinical study titled "Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed Lens". To evaluate and compare the performance of a new contact lens to a marketed contact lens.

What is the current status of trial NCT01484054?

This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2011-11. Estimated completion is 2012-02.

What conditions does trial NCT01484054 study?

This clinical trial studies the following conditions: Refractive Ametropia.

What interventions are being tested in trial NCT01484054?

The interventions under investigation include: etafilcon A with print and PVP for dark eyes (EAPVPDE) (DEVICE), etafilcon A control lens (EADE) (DEVICE).

Who is sponsoring clinical trial NCT01484054?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01484054 being conducted?

This trial has 6 study locations across Connecticut, Florida, Kansas, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Refractive Ametropia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Refractive Ametropia

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.